The data supporting its use is based on in vitro cell culture studies and animal model research demonstrating its superior local potency
If progress feels slow right now, thats normalthe medication is designed to build gradually, and the strongest appetite-suppressing effects tend to come later in treatment
In another observational study of patients aged 40 years with T2D, body mass index 25 kg/m 2 , and pre-existing ischemic heart disease, tirzepatide was associated with a lower rate of the primary composite outcome of all-cause mortality, myocardial infarction, and ischemic stroke (HR 0.60, 95% CI 0.430.84), as well as reductions in all individual components of the composite outcome [29]
A realistic way to think about it: expect early appetite changes in weeks one to three, noticeable weight loss by weeks four to eight, and the full extent of what tirzepatide can do for your body over the first year of consistent use
The most common side effects of Mounjaro are nausea, vomiting (in severe cases especially if you eat more than your body wants), diarrhea, abdominal pain (stomach ache) and constipation (unable to poop), dehydration (often from not drinking enough water)
The Summary of Product Characteristics (SmPC) for Wegovy, as approved by the Medicines and Healthcare products Regulatory Agency (MHRA), does not list previous cholecystectomy as a contraindication or precaution
